Labcorp Agrees to Acquire BioReference Health Assets for $722 Million
Labcorp agreed to acquire select assets of BioReference Health, a subsidiary of OPKO Health, for $722 million in cash at closing.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Labcorp agrees to buy select BioReference Health assets for $722 million plus earnout
Labcorp agreed to acquire select BioReference Health assets from OPKO Health for $722 million cash, subject to closing revenue adjustments. The deal includes the 4Kscore prostate cancer test, with up to $150 million in additional earnout payments tied to test revenue. Acquired assets include clinical and specialty test